This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1956 Oct;232(4):369-77.

doi: 10.1097/00000441-195610000-00001.

Requirements for persistent immunity to poliomyelitis

J E SALK

PMID: 13362246
DOI: 10.1097/00000441-195610000-00001

Requirements for persistent immunity to poliomyelitis

J E SALK. Am J Med Sci. 1956 Oct.

. 1956 Oct;232(4):369-77.

doi: 10.1097/00000441-195610000-00001.

Author

J E SALK

PMID: 13362246
DOI: 10.1097/00000441-195610000-00001

No abstract available

PubMed Disclaimer

Similar articles

Requirements for persistent immunity to poliomyelitis.
SALK JE. SALK JE. Trans Assoc Am Physicians. 1956;69:105-15. Trans Assoc Am Physicians. 1956. PMID: 13380952 No abstract available.
[On the development of immunity to poliomyelitis viruses in Viennese children].
POETSCH F, KREPLER P. POETSCH F, et al. Z Kinderheilkd. 1960;84:277-86. Z Kinderheilkd. 1960. PMID: 14433629 German. No abstract available.
REQUIREMENTS for biological substances. 1. General requirements for manufacturing establishments and control laboratories. 2. Requirements for poliomyelitis vaccine (inactivated). Report of a study group.
[No authors listed] [No authors listed] World Health Organ Tech Rep Ser. 1959;178:1-30. World Health Organ Tech Rep Ser. 1959. PMID: 13858460 No abstract available.
Survey for sero-immunity to poliomyelitis in Peru and Colombia with comments on the changing pattern of occurrence of poliomyelitis in tropical areas.
GELFAND HM, FOX JP, MONTOYA JA. GELFAND HM, et al. J Trop Pediatr (Lond). 1957 Sep;3(2):51-61. doi: 10.1093/oxfordjournals.tropej.a057457. J Trop Pediatr (Lond). 1957. PMID: 13463964 No abstract available.
[Immunity against poliomyelitis in childhood, in Greece, as demonstrated by hemagglutination tests].
CHOREMES KB, ANASTASEA-BLACHOU K. CHOREMES KB, et al. Hell Iatr. 1960 Feb;29:119-30. Hell Iatr. 1960. PMID: 13810002 German. No abstract available.

See all similar articles

Cited by

Prevalence of poliomyelitis neutralizing antibodies in Norwegian school children before vaccination.
ULSTRUP JC, MEMMER R. ULSTRUP JC, et al. Arch Gesamte Virusforsch. 1959;9:348-59. doi: 10.1007/BF01248827. Arch Gesamte Virusforsch. 1959. PMID: 13840330 No abstract available.
Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).
Duintjer Tebbens RJ, Pallansch MA, Kim JH, Burns CC, Kew OM, Oberste MS, Diop OM, Wassilak SG, Cochi SL, Thompson KM. Duintjer Tebbens RJ, et al. Risk Anal. 2013 Apr;33(4):680-702. doi: 10.1111/risa.12022. Epub 2013 Mar 7. Risk Anal. 2013. PMID: 23470192 Free PMC article.
Poliovirus antibody response after various vaccination schedules and at different ages.
MACLEOD DR, ARMSTRONG CW, MOSS GW, POTTER FC, WILSON RJ. MACLEOD DR, et al. Can Med Assoc J. 1959 Sep 15;81(6):443-9. Can Med Assoc J. 1959. PMID: 14419587 Free PMC article. No abstract available.
Living Poliomyelitis Vaccine.
[No authors listed] [No authors listed] Can Med Assoc J. 1957 Feb 15;76(4):306-7. Can Med Assoc J. 1957. PMID: 20325433 Free PMC article. No abstract available.
[Results of an experimental vaccination against poliomyelitis].
MELEN B, WESSLEN T, OLIN G. MELEN B, et al. Arch Gesamte Virusforsch. 1959;9(1):11-24. doi: 10.1007/BF01240999. Arch Gesamte Virusforsch. 1959. PMID: 13650536 Undetermined Language. No abstract available.

See all "Cited by" articles

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.